Fibromyalgia and the complex regional pain syndrome: Similarities in pathophysiology and treatment

Metabolism: Clinical and Experimental

Volumn 59, Issue SUPPL. 1, 2010, Pages

  Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

CHRONIC PAIN; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FIBROMYALGIA; HALLUCINATION; HUMAN; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; COMPLEX REGIONAL PAIN SYNDROMES;

COMPLEX REGIONAL PAIN SYNDROMES; FIBROMYALGIA; HUMANS; KETAMINE;

EID: 77956607108     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.008     Document Type: Review

References (23)

1. Cohen M.L., and Quintner J.L. Fibromyalgia syndrome, a problem of tautology Lancet 342 1993 906 909
2. Wolfe F., Smythe H.A., and Yunus M.H. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia Arthritis Rheum 33 1990 160 172
3. Bennett R.M. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia Mayo Clin Proc 74 1999 385 398
4. Goldenberg D.L., Breekhardt C., and Crofford L. Management of fibromyalgia syndrome JAMA 292 2004 2388 2395
5. Dadabhoy D., Crofford L.J., and Spaeth M. Evidence-based biomarkers for fibromyalgia syndrome Arthritis Res Ther 10 2008 211
6. Cook D.B., Lange G., and Ciccone D.S. Functional imaging of pain in patients with primary fibromyalgia J Rheumatol 31 2004 364 378
7. Dworkin R.H., and Kirkpatrick P. Pregabalin Nat Rev Drug Discov 4 2005 455 456
8. Mainguy Y. Functional magnetic resonance imagery (fMRI) in fibromyalgia and in response to milnacipran Hum Psychopharmacol Clin Exp 24 2009 S19 S23
9. Costigan M., Scholz J., and Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage Ann Rev Neurosci 32 2009 1 32
10. Sörensen J., Bengtsson A., and Bäckman E. Pain analysis in patients with fibromyalgia Scan J Rheumatol 24 1995 360 365
11. Price D.D., Mao J., and Frenk H. The N-methyl-d-aspartate receptor antagonist destromethorphan selectively reduces temporal summation of second pain in man Pain 59 1994 165 174
12. Hocking G., and Cousins M.J. Ketamine in chronic pain management: an evidence-based review Anesth Analg 97 2003 1730 1739
13. Guedj E., Cammilleri S., and Colavolpe C. Follow-up of pain processing recovery after ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT Eur J Nucl Med Mol Imaging 34 2007 2115 2116
14. Schwartzman R.J., Erwin K.L., and Alexander G.M. The natural history of complex regional pain syndrome. Clin J Pain 25 2009 273 280
15. Schwartzman R.J., Alexander G.M., and Grothusen J. Pathophysiology of complex regional pain syndrome. Expert Rev Neurotherapeutics 6 2006 669 681
16. Woolf C.J., and Wall P.D. The relative effectiveness of C primary afferent fibres of different origins in evoking a prolonged facilitation of the flexor reflex in the rat J Neurosci 6 1986 1433 1442
17. Graven-Nielsen T., Kendall S.A., and Henriksson K.G. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients Pain 85 2000 483 491
18. Eide P.K., Stubhaug A., and Oye I. Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia Pain 61 1995 221 228
19. Takahashi H., Miyazaki M., and Nanbu T. The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case Pain 75 1998 391 394
20. Harbut R.E., and Correll G.E. Successful treatment of a nine-year-old case of complex regional pain syndrome type-1 (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient Pain Med 3 2002 147 155
21. Kiefer R.T., Rohr P., and Ploppa A. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study Pain Med 9 2008 1173 1201
22. Schwartzman R.J., Alexander G.M., and Grothusen J.R. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study Pain 147 2009 107 115
23. Zarate C.A., Singh J.B., and Carlson P.J. A randomized trial of an N-methyl-df-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatr 63 2006 856 864